Inozyme Pharma Inc INZY:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 02/03/23 EST
2.86quote price arrow up+0.41 (+16.73%)
Volume
331,915
52 week range
0.99 - 7.98
Loading...
  • Open2.45
  • Day High2.90
  • Day Low2.45
  • Prev Close2.45
  • 52 Week High7.98
  • 52 Week High Date02/11/22
  • 52 Week Low0.99
  • 52 Week Low Date12/30/22

Key Stats

  • Market Cap115.528M
  • Shares Out40.39M
  • 10 Day Average Volume0.38M
  • Dividend-
  • Dividend Yield-
  • Beta0.87
  • YTD % Change172.38

KEY STATS

  • Open2.45
  • Day High2.90
  • Day Low2.45
  • Prev Close2.45
  • 52 Week High7.98
  • 52 Week High Date02/11/22
  • 52 Week Low0.99
  • 52 Week Low Date12/30/22
  • Market Cap115.528M
  • Shares Out40.39M
  • 10 Day Average Volume0.38M
  • Dividend-
  • Dividend Yield-
  • Beta0.87
  • YTD % Change172.38

RATIOS/PROFITABILITY

  • EPS (TTM)-2.26
  • P/E (TTM)-1.26
  • Fwd P/E (NTM)-1.68
  • EBITDA (TTM)-67.171M
  • ROE (TTM)-51.60%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)3.02%

EVENTS

  • Earnings Date03/13/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Inozyme Pharma Inc

 

Content From Our Affiliates

Profile

MORE
Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. The Company is focused on developing therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. It is also focused on developing a therapy to treat the rare genetic diseases of Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) and ATP-binding cassette sub-family C member 6 (ABCC6) deficiencies. The Company's lead product...
Douglas Treco Ph.D.
Independent Chairman of the Board
Axel Bolte
President, Chief Executive Officer, Director
Sanjay Subramanian
Chief Financial Officer, Principal Accounting Officer
Address
321 SUMMER STREET, SUITE 400
Boston, MA
02210
United States

Top Peers

SYMBOLLASTCHG%CHG
IRON
Disc Medicine Inc
23.23+2.49+12.01%
IFRX
InflaRx NV
2.21+0.01+0.45%
CLNN
Clene Inc.
1.59-0.03-1.85%
ELYM
Eliem Therapeutics Inc
3.37-0.15-4.26%
LBPH
Longboard Pharmaceuticals Inc
5.02+0.04+0.90%